Hyperkalemia Completed Phase 4 Trials for Patiromer (DB09263)

Also known as: Hyperkalemia (HK) / Hyperkalaemia / Hyperpotassaemia / Hyperpotassemia / Potassium overload / Potassium [K] excess

IndicationStatusPhase
DBCOND0003949 (Hyperkalemia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03183778Use of Patiromer to Transition Chronic Kidney Disease Patients With Hyperkalemia to a Plant-rich Diet.Treatment
NCT02694744Patiromer With or Without Food for the Treatment of HyperkalemiaTreatment
NCT03229265Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving PatiromerTreatment